Rotavirus-Specific Immunoglobulin A Responses Are Impaired and Serve as a Suboptimal Correlate of Protection Among Infants in Bangladesh

Abstract

BackgroundRotavirus (RV)–specific immunoglobulin A (IgA) responses following oral RV vaccination are impaired in low-income countries, where the utility of RV-IgA as a correlate of protection (CoP) remains unclear. In a monovalent oral RV vaccine (Rotarix) efficacy trial among infants in Dhaka, Bangladesh, we identified factors associated with poor RV-IgA responses and explored the utility of RV-IgA as a CoP.MethodsInfants were randomized to receive Rotarix or no Rotarix at 10 and 17 weeks of life and followed with active diarrheal surveillance. RV-IgA concentration, seroconversion, and seropositivity were determined at 18 weeks of life and analyzed for correlation(s) with rotavirus diarrhea (RVD) and for contribution to Rotarix vaccine effect.ResultsAmong vaccinated infants, overall RV-IgA geometric mean concentration was 21 U/mL; only 27% seroconverted and 32% were seropositive after vaccination. Increased RV-specific maternal antibodies significantly impaired immunogenicity. Seroconversion was associated with reduced risk of RVD through 1 year of life, but RV-IgA seropositivity only explained 7.8% of the vaccine effect demonstrated by the clinical endpoint (RVD).ConclusionsRV-IgA responses were low among infants in Bangladesh and were significantly impaired by maternal antibodies. RV-IgA is a suboptimal CoP in this setting; an improved CoP for RV in low-income countries is needed.Clinical Trials RegistrationNCT01375647.

The Impact of Improved Water, Sanitation, and Hygiene on Oral Rotavirus Vaccine Immunogenicity in Zimbabwean Infants: Substudy of a Cluster-randomized Trial

“…RVV seroconversion in the WASH group was 39% at best (Supplementary Table 5), which is still far lower than in developed countries (67%–98%) [5]. It is, however, consistent with recent data from other developing countries: RVV seroconversion was 24% in Malawi [32] and 27% in Bangladesh [33]. Taken together, there are important implications of these findings.…”

Interventions to improve oral vaccine performance: a systematic review and meta-analysis

“…Our study has several limitations. First, we used seroconversion as our primary outcome for meta-analysis; however, serological markers do not always correlate with protection from disease, particularly for RVV, for which rotavirus-specific IgA is a poor correlate of protection in low-income countries 67 . Second, there were differences in study design and significant heterogeneity between studies for several interventions, despite our strict inclusion criteria, probably reflecting the range of ages, settings, and vaccine types across studies.…”

Intracellular neutralisation of rotavirus by VP6-specific IgG

“…The most widely used correlate of protection for rotavirus in humans following vaccination is rotavirus-specific serum IgA titre [56,57]. This measure is often considered to be imperfect, with poor correlation between IgA seroconversion and protection from severe rotavirus-induced gastroenteritis in several studies [56,58]. We propose that omitting to measure rotavirus-specific IgG could be part of the explanation as to why serum IgA titres are not an optimal correlate of protection.…”